UT Southwestern: Simmons Cancer Center

Dallas, Texas 75390

5 studies enrolling now · 8 studies all time

What they study most

AML With Mutated NPM1, Acute Leukemia of Ambiguous Lineage, Acute Leukemia of Ambiguous Lineage in Relapse, Acute Myeloid Leukemia, Acute Myeloid Leukemia Recurrent, Acute Myeloid Leukemia, in Relapse, Brain Metastases, Brain Tumor, Brain Tumor - Metastatic, Brain Tumor, Adult Meningioma, Brain Tumor, Adult: Glioblastoma, Brain Tumor, Primary

Studies at this site

• Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia — Recruiting now
• Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles) — Recruiting now
• KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors — Recruiting now
• A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML — Recruiting now
• Intraperitoneal Oxaliplatin and Fluorouracil for the Treatment of Patients With Peritoneal Metastases From Colorectal Cancer — Running, not enrolling
• Study of Selinexor and Venetoclax in Combination With Chemotherapy in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia — Running, not enrolling
• Post-Surgical Stereotactic Radiotherapy (SRT) Versus GammaTile-ROADS (Radiation One and Done Study) — Running, not enrolling
• Study of CYH33 in Combination With Olaparib an Oral PARP Inhibitor in Patients With Advanced Solid Tumors. — Stopped early